Form 8-K

8-K — Hoth Therapeutics, Inc.

Accession: 0001213900-26-061252

Filed: 2026-05-27

Period: 2026-05-20

CIK: 0001711786

SIC: 2834 (PHARMACEUTICAL PREPARATIONS)

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — ea0292213-8k_rocket.htm (Primary)

EX-3.1 — CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION DATED MAY 20, 2026 (ea029221301ex3-1.htm)

EX-99.1 — PRESS RELEASE DATED MAY 27, 2026 (ea029221301ex99-1.htm)

GRAPHIC (ea029221301_ex3-1img1.jpg)

GRAPHIC (ea029221301_ex3-1img2.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0292213-8k_rocket.htm · Sequence: 1

false

--12-31

0001711786

2026-05-20

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

May 20, 2026

Hoth Therapeutics, Inc. (Now Known As Rocket One Inc.)

(Exact name of registrant as specified in its charter)

Nevada

001-38803

82-1553794

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I. R. S. Employer

Identification No.)

720 Monroe Street, Suite E514

Hoboken, NJ 07030

(Address of principal executive offices, including

ZIP code)

(866) 239-7459

(Registrant’s telephone number, including

area code)

Hoth Therapeutics, Inc.

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.0001 par value

RKTO

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.03 Amendments to Articles of Incorporation

or Bylaws; Change in Fiscal Year.

On May 20, 2026, Rocket One Inc. (formerly, Hoth Therapeutics, Inc.) (the “Company”) filed a Certificate of Amendment

to its Articles of Incorporation, as amended (the “Charter Amendment”), with the Secretary of State of the State of Nevada

to change the name of the Company from “Hoth Therapeutics, Inc.” to “Rocket One Inc.” effective as of May 26,

2026 (the “Name Change”).

Pursuant to Nevada Revised Statutes Section 78.390(8),

no stockholder approval was required for the Charter Amendment because it only related to a name change. A copy of the Charter Amendment

is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

In connection with the Name Change, the Company’s

trading symbol for its common stock will begin trading on The Nasdaq Capital Market on May 28, 2026 under the symbol “RKTO”

(the “Symbol Change”).

Neither the Name Change, nor the Symbol Change,

affects the rights of the Company’s shareholders, and shareholders do not need to take any action in connection with the Name Change

or the Symbol Change. The CUSIP number for the Company’s common stock will remain 44148G204.

Item 8.01 Other Events.

On May 27, 2026, the Company issued a press release

announcing, among other things, the Name Change and Symbol Change. A copy of the press release is attached hereto as Exhibit 99.1 and

is incorporated herein by reference.

As previously reported on a Current Report on Form 8-K filed with the SEC on May 6, 2026, on April 22, 2026, the Company filed Articles

of Incorporation with the Secretary of State of the State of Nevada for the formation of its new wholly-owned subsidiary, Rocket One Inc.

On May 20, 2026, the Company filed a Certificate of Amendment to the Articles of Incorporation with the Secretary of State of the State

of Nevada to change the name of the subsidiary from “Rocket One Inc.” to “Rocket One.0 Inc.” effective as of May

26, 2026.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibit listed in

the following Exhibit Index is filed as part of this Current Report on Form 8-K.

Exhibit No.

Description of Exhibit

3.1

Certificate of Amendment to Articles of Incorporation dated May 20, 2026

99.1

Press release dated May 27, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

-1-

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Date: May 27, 2026

Rocket One Inc. (formerly Hoth Therapeutics, Inc.)

/s/ Robb Knie

Robb Knie

Chief Executive Officer

-2-

EX-3.1 — CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION DATED MAY 20, 2026

EX-3.1

Filename: ea029221301ex3-1.htm · Sequence: 2

Exhibit 3.1

Business Number E0234272017 - 6 Filed in the Office of Filing Number 20265755587 Secretary of State State Of Nevada Filed On 5/20/2026 2:43:00 PM Number of Pages 2

FRANCISCO V. AGUILAR Secretary of State 401 North Carson Street Carson City, Nevada B97d1 - 42D1 (775) 684 - 5708 Website: www.nvsos.gov Profit Corporation: Certificate of Amendment (PURSUANT TO NRS 78 380 & 78 385 78.390) Certificate to Accompany Restated Articles or Amended and Restated Articles ‹PURSUANT TO NRS 78.403) Officer's Statement (PURSUANT TO NRS 80.030) 4. Effective Date and Time: (Optional) D a ! l3 05/26/2026 T i= € :o0 AM (must not be later than 90 days after the certificate is filed) Changes to takes the following effect. ;r The entity name has been amended. The registered agent has been changed. (attach Certificate of Acceptance from new registered agent) The purpose of the entity has been amended. The authorized shares have been amended. The directors, managers or general partners have been amended. IRS tax language has been added. Articles have been added. Articles have been deleted. Other. The articles have been amended as follows: (provide article numbers, if available) 1. Name of Corporation: Rocket One Inc. (attach additional page(s) if necessary) 5. Information Being Changed: (Domestic corporations only) 6. Signature: (Required) X Signature of Officer or Authorized Signer ign user o Au ed S gner President and Chairman Title Authorized Signer Title *If any proposed amendment would alter or change any preference or any relative or other right given to any class or series of outstanding shares, than the amendment must be approved by the vote, in addition to the affirmative vote otherwise required, of the holders of shares representing a majority of the voting power of each class or series affected by the amendment regardless to limitations or restrictions an the voting power thereof. Please include any required or optional information in space below: (attach additional page(s) if necessary) This form must be accompanied by appropriate fees. Page 2 of 2 Revised. 9/1/2023

EX-99.1 — PRESS RELEASE DATED MAY 27, 2026

EX-99.1

Filename: ea029221301ex99-1.htm · Sequence: 3

Exhibit 99.1

Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq:

RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing

for Space and Defense Applications

Company Adopts Space-Focused Identity, New Ticker

“RKTO,” and Exclusive License of AI Chip Architecture Designed for Ultra-Low-Power, Radiation-Tolerant Computing in Space

and Defense Applications

HOBOKEN, N.J. — May 27, 2026 —

Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“Hoth” or the “Company”) today announced that, following the strategic

repositioning disclosed on May 19, 2026, it has completed the legal change of its corporate name to Rocket One Inc. (“Rocket

One”) effective as of May 26, 2026 and will begin trading on The Nasdaq Capital Market under the new ticker symbol “RKTO”

at the open of trading on May 28, 2026. The Company’s common stock will cease trading under the symbol “HOTH”

at the close of trading on May 27, 2026.

The Rocket One identity reflects the Company’s

strategic focus on the orbital economy: the next generation of satellites, defense platforms, and space-based AI systems that depend on

hardware capable of operating reliably in space. The Company’s legacy biotechnology programs will continue to be advanced under

a wholly owned subsidiary.

Why Space, and Why Now

The commercial space sector is undergoing a structural

shift. Falling launch costs, the rapid growth of small satellites, and rising defense demand for resilient orbital assets are creating

a new layer of infrastructure above the atmosphere. As more workloads move from ground stations to spacecraft — from Earth observation

and signal processing to autonomous navigation and on-orbit AI — the limiting factor is no longer getting to orbit. It is the ability

to run powerful computing on satellites that have very little power available, generate heat that is hard to dissipate, and operate in

an environment of constant radiation.

Today’s standard computer chips are designed

for terrestrial data centers, not for low-Earth orbit. They consume power satellites cannot spare, lose data when the satellite power

cycles on and off, and require heavy shielding to survive radiation. Rocket One is positioning itself directly at this bottleneck.

The Technology Platform

Rocket One holds exclusive rights to a next-generation

nanomagnetic AI chip technology. Unlike conventional chips that move electrons through silicon, this new class of chip uses magnetism

at the nanoscale to perform the core calculations that drive artificial intelligence.

Properties of the technology that make it especially

well-suited for space and defense applications include:

● Holds data without power. The chip retains computational results even when powered off, intended

to eliminate data loss during satellite power cycles and eclipse periods.

● Extremely low energy use. The design targets dramatically lower energy per calculation than conventional

AI chips, intended to address the severe power limits of small satellites and deep-space platforms.

● Very small footprint. Each compute cell occupies only a tiny fraction of the area of a conventional

chip element, supporting the strict mass and volume constraints of nanosatellite payloads.

● Built for edge AI. Computing on the device itself reduces dependence on ground-link bandwidth and

limits exposure to interception or jamming — increasingly valued by defense and national security customers.

Rocket One’s Strategic Aperture

Building on the previously disclosed formation

of its space subsidiary, now Rocket One.0 Inc., Rocket One intends to pursue three converging opportunities: (i) AI chip and memory hardware

engineered for orbital and high-radiation environments; (ii) nano-launch and nanosatellite enablement; and (iii) defense and national

security applications where radiation tolerance, energy efficiency, and on-device intelligence intersect. The Company believes these markets

are mutually reinforcing and that its licensed nanomagnetic chip platform offers a differentiated entry point into each.

What Stockholders Should Know

● New Corporate Name: Rocket One Inc.

● New Ticker Symbol: RKTO (Nasdaq Capital Market)

● Former Ticker Symbol: HOTH (Nasdaq Capital Market)

● Effective Date of Name Change: May 26, 2026

● Effective Date of Ticker Symbol Change: May 28, 2026

● CUSIP: 44148G204 (no change)

● Corporate Website: www.rocketone.space

Management Commentary

“Space is moving from a launch story to

a compute story. We believe that the platforms that will define the next decade in orbit will be the ones that can think for themselves

under power and radiation constraints that ground-based hardware was never designed to handle. The rebrand to Rocket One reflects where

we are positioning this Company,” said Robb Knie, Chief Executive Officer. Knie continued, “Our exclusive licenses give us a credible technical foundation, and the RKTO ticker is a signal to investors, partners, and customers

that our focus is now on the orbital economy.”

About Rocket One Inc.

Rocket One Inc. (formerly Hoth Therapeutics, Inc.)

is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology

designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The

Company holds exclusive rights to certain technologies, including a nanomagnetic matrix multiplier architecture intended as a hardware

accelerator for machine learning and AI workloads, and related magnetic memory technology with potential applications in radiation-tolerant

computing for defense and space systems. The Company is also positioned to pursue opportunities in nano-launch systems and nanosatellite

deployment. The Company’s biotechnology pipeline, including, but not limited to, HT-001, HT-KIT, HT-ALZ, and its GDNF-based metabolic

program, will continue to be advanced under a wholly owned subsidiary.

Forward-Looking Statements

This press release contains “forward-looking

statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange

Act of 1934, as amended, including, without limitation, statements regarding the Company’s strategic repositioning, the development

potential of the licensed technologies, the suitability of those technologies for orbital, defense, and other applications, anticipated

future operations and market opportunities. You should not place reliance on these forward-looking

statements, which include words such as “could,” “believe,” “anticipate,” “intend,” “estimate,”

“expect,” “may,” “continue,” “predict,” “potential,” “project” or similar

terms, variations of such terms, or the negative of those terms. There are a number of factors that could cause actual events to differ

materially from those indicated by such forward-looking statements. These forward-looking statements are based on the Company’s

current expectations and assumptions and are subject to numerous risks and uncertainties, including, without limitation: the early-stage

nature of the licensed technologies, which have not been fabricated as integrated devices, validated in space environments, or qualified

for any commercial or government program, and the absence of any commercial product; the substantial additional capital the Company will

require to fabricate, test, and qualify the licensed technologies, including for radiation tolerance and space deployment; the long development

timelines associated with novel semiconductor and materials platforms; competition from larger, better-funded and well recognized companies

in the semiconductor, AI hardware, space, and defense computing sectors; the Company’s ability to recruit qualified leadership and

technical personnel in nanomagnetic devices, semiconductor engineering, and aerospace systems; the Company’s ability to comply with

diligence milestones under the Virginia Commonwealth University license agreements, the failure of which could result in loss of license

rights; intellectual property risks; export control and government contracting risks associated with defense and space applications; and

the risks inherent in a strategic pivot. Additional risk factors are described in the Company’s filings with the Securities and

Exchange Commission (“SEC”) including the Company’s most recent Annual Report on Form 10-K and the Company’s other

filings made with the SEC. Although the Company believes that the expectations reflected

in the forward-looking statements are reasonable, the Company cannot guarantee such outcomes. The Company may not realize its expectations,

and its beliefs may not prove correct. All such statements speak only as of the date made. Consequently, forward-looking statements should

be regarded solely as the Company’s current plans, estimates, and beliefs. Investors should not place undue reliance on forward-looking

statements. The Company cannot guarantee future results, events, levels of activity, performance, or achievements. The Company does not

undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information,

future events, or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable

law.

Investor Contact

LR Advisors LLC

Email: investorrelations@rocketone.space

Phone: (678) 570-6791

www.rocketone.space

GRAPHIC

Filename: ea029221301_ex3-1img1.jpg · Sequence: 4

Binary file (437980 bytes)

Download ea029221301_ex3-1img1.jpg

GRAPHIC

Filename: ea029221301_ex3-1img2.jpg · Sequence: 5

Binary file (603408 bytes)

Download ea029221301_ex3-1img2.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 10

v3.26.1

Cover

May 20, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

May 20, 2026

Current Fiscal Year End Date

--12-31

Entity File Number

001-38803

Entity Registrant Name

Hoth Therapeutics, Inc. (Now Known As Rocket One Inc.)

Entity Central Index Key

0001711786

Entity Tax Identification Number

82-1553794

Entity Incorporation, State or Country Code

Entity Address, Address Line One

720 Monroe Street

Entity Address, Address Line Two

Suite E514

Entity Address, City or Town

Hoboken

Entity Address, State or Province

Entity Address, Postal Zip Code

07030

City Area Code

866

Local Phone Number

239-7459

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common stock, $0.0001 par value

Trading Symbol

RKTO

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

Entity Information, Former Legal or Registered Name

Hoth Therapeutics, Inc.

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name:

dei_CurrentFiscalYearEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:gMonthDayItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

Former Legal or Registered Name of an entity

+ References

No definition available.

+ Details

Name:

dei_EntityInformationFormerLegalOrRegisteredName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration